Literature DB >> 8031065

In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.

M E Juvin1, G Potel, J Caillon, Y Q Xiong, D Bugnon, P Le Conte, D I Baron, H B Drugeon.   

Abstract

The critical concentrations of pefloxacin and ciprofloxacin in serum, corresponding to the lowest concentration in serum able to achieve a 2-log-unit reduction in the CFU in vegetations after a 24-h exposure at a steady-state concentration obtained by a continuous intravenous infusion, were determined in an experimental model of Serratia marcescens endocarditis in rabbits. In vitro data showed that the MICs of ciprofloxacin and pefloxacin were 0.06 and 0.25 mg/liter, respectively. The killing curves indicated a maximum killing rate at a concentration four times that of the MICs. In vivo, the critical concentrations of pefloxacin and ciprofloxacin in serum were 0.4 and 0.24 mg/liter, respectively, corresponding to a concentration of four times the MICs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031065      PMCID: PMC284562          DOI: 10.1128/AAC.38.4.883

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 2.  The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.

Authors:  C S Lewin; I Morrissey; J T Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

3.  Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.

Authors:  K Borner; G Höffken; H Lode; P Koeppe; C Prinzing; P Glatzel; R Wiley; P Olschewski; B Sievers; D Reinitz
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

4.  Spiral plate method for bacterial determination.

Authors:  J E Gilchrist; J E Campbell; C B Donnelly; J T Peeler; J M Delaney
Journal:  Appl Microbiol       Date:  1973-02

5.  Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding.

Authors:  G Potel; N P Chau; B Pangon; B Fantin; J M Vallois; F Faurisson; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 6.  Comparative activity of the 4-quinolones.

Authors:  I Phillips; A King
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

7.  Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.

Authors:  L J Chalkley; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

8.  In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.

Authors:  J E Rudin; C W Norden; E M Shinners
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.

Authors:  J E Leggett; B Fantin; S Ebert; K Totsuka; B Vogelman; W Calame; H Mattie; W A Craig
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

10.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
View more
  2 in total

1.  Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.

Authors:  Y Q Xiong; G Potel; J Caillon; G Stephant; F Jehl; D Bugnon; P Le Conte; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

2.  Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo.

Authors:  D Bugnon; G Potel; Y Q Xiong; J Caillon; D Navas; C Gras; M F Kergueris; P Le Conte; F Jehl; D Baron; H Drugeon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.